Abstract
This systematic review and meta-analysis identifies a pooled prevalence of concomitant osteomyelitis in paediatric hip septic arthritis at 31.8-34.5%, employing rigorous methodologies such as sensitivity analyses and stratified assessments that enhance the reliability of the findings despite limitations like small sample sizes and exclusion of non-English studies. These insights are essential for guiding future research and informing treatment strategies, ultimately supporting clinicians in making informed decisions to improve patient care in paediatric orthopedics.
Introduction
Paediatric hip septic arthritis (SA) is a critical orthopedic emergency characterized by bacterial invasion of the joint space. If not addressed promptly, it can lead to irreversible cartilage destruction (chondrolysis) or bone death (osteonecrosis). A significant clinical challenge is the frequent coexistence of osteomyelitis (OM)—an infection of the adjacent bone.
The presence of undetected osteomyelitis often results in the failure of initial joint drainage, necessitating secondary surgical interventions and increasing the risk of severe hip deformities. Historically, reported prevalence rates for this dual infection have been inconsistent, ranging from 12% to 75%. This study provides a comprehensive systematic review and meta-analysis to establish a reliable global prevalence estimate and identify the factors influencing these rates.
Methodology
Following PRISMA guidelines, the authors conducted an extensive search of PubMed, Embase, and the Cochrane Library for relevant studies published through September 2024.
Key methodological components included: * Inclusion Criteria: Studies involving patients ≤ 18 years old with hip SA and at least five documented cases. * Statistical Modeling: A random-effects meta-analysis was utilized to account for variability across different hospital settings and regions. * Quality Assessment: The Joanna Briggs Institute (JBI) checklist was used to categorize studies as "High" or "Fair" quality. * Subgroup Analysis: Data were stratified by age, geography, study quality, and time period (1976–2010 vs. 2011–2023).
The final dataset comprised 21 retrospective studies encompassing 684 paediatric cases from the USA, China, India, Turkey, Germany, the UK, and South Korea.
Results and Key Insights
The meta-analysis revealed a pooled prevalence of 33.2% (95% CI: 27.3% – 39.8%). This "One-Third Rule" suggests that for every three children presenting with a septic hip, one likely has an underlying bone infection requiring more aggressive management.
The MRI Effect
One of the most notable findings was the impact of diagnostic technology. Prevalence rates were significantly higher in studies published after 2011 (35.2%) compared to older studies (29.4%). This increase is attributed to the widespread adoption of MRI, which is far more sensitive than traditional X-rays at detecting early-stage bone marrow edema and abscesses.
Geographical and Quality Disparities
- Geography: There was a statistically significant difference in prevalence by continent (P=0.008), with the USA reporting higher rates (36.6%) compared to Asia (29.0%). This may reflect differences in diagnostic protocols or the prevalence of specific pathogens like MRSA.
- Study Quality: "High" quality studies reported a higher prevalence (35.9%) than "Fair" quality studies (30.8%), suggesting that rigorous diagnostic standards are more likely to uncover concomitant infections.
Discussion and Limitations
While the study provides a robust estimate, several limitations persist. All included studies were retrospective, introducing inherent sampling bias. Furthermore, the review was restricted to English-language publications, and individual sample sizes were often small. There is also a lack of a universal "gold standard" for diagnosing concomitant OM, with some studies relying on MRI and others on surgical findings.
Future research should focus on prospective, multi-center studies with larger cohorts to investigate the relationship between symptom duration and the development of osteomyelitis. Standardizing diagnostic protocols—specifically the early use of MRI—is essential to prevent the long-term morbidity associated with missed bone infections.
Summary updated